Human distal airways contain a multipotent secretory cell that can regenerate alveoli
Maria C. Basil(Boston University), Edward E. Morrisey(Penn Center for AIDS Research), Edward Cantu(Hospital of the University of Pennsylvania), Madison M. Kremp(University of Pennsylvania), Xiaoming Liu(Baylor College of Medicine), Rebecca Windmueller(University of Pennsylvania), John F. Engelhardt(University of Iowa), Yun Ying(University of Pennsylvania), Joshua M. Diamond(California University of Pennsylvania), Joseph D. Planer(Pulmonary and Allergy Associates), Harold A. Chapman(University of California, San Francisco), Kathleen M. Stewart(University of Pennsylvania), Katherine J. Slovik(Penn Center for AIDS Research), Darrell N. Kotton(Boston University), Jaymin J. Kathiriya(Icahn School of Medicine at Mount Sinai), M. Oyster(University of Pennsylvania), Katherine B. McCauley(Boston University), Apoorva Babu(University of Pennsylvania), Fabian L. Cardenas‐Diaz(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shanru Li(University of Pennsylvania), Michael P. Morley(University of Pennsylvania), Shah S. Hussain(Florida International University), Jason D. Christie(University of Pennsylvania), Su Zhou(University of Pennsylvania), Justine Carl(University of Pennsylvania), Steven M. Rowe(University of Alabama at Birmingham), Alexis N. Brumwell(University of California, San Francisco), Jeremy Katzen(Translational Therapeutics (United States))
Cited by 321
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
|Nature Communications|2020|924
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799